Exosomal miR-146a-3p modulates neural stem cell fate through UCHL1 downregulation in spinal cord injury:implications for neuroregenerationOA
Spinal cord injury(SCI)poses a substantial challenge within the field of regenerative medicine,primarily because of its high incidence of disability and the paucity of effective therapeutic interventions.This study explores the involvement of cerebrospinal fluid(CSF)exosomes in the differentiation of neural stem cells(NSCs)following SCI,with a particular emphasis on the miR-146a-3p/UCHL1 signaling axis.Using an SCI animal model,we analyze the molecular composition of CSF and its influence on NSC fate through bioinformatics approaches,dual-luciferase reporter assays,and in vitro differentiation experiments.Differential expression analyses reveal a significant upregulation of miR-146a-3p in CSF-derived exosomes post-SCI,which directly targets and suppresses UCHL1,a pivotal regulator of neuronal differentiation.Overexpression of UCHL1 facilitates the differentiation of NSCs into neurons and enhances functional recovery,whereas its downregulation leads to increased astrocytic differentiation and fibrotic scar formation.These findings are corroborated through immunofluorescence,western blot analysis,and behavioral assessments.In summary,our study identifies miR-146a-3p as a critical regulator in SCI,offering novel insights into the role of microRNAs in modulating neural stem cell fate and promoting neuronal regeneration.Our study highlights the pivotal role of CSF exosomal miRNAs in determining NSC fate,paving the way for systemic interventions in injured spinal cord injury repair.These findings underscore the importance of exosomal miRNAs in modulating the spinal cord microenvironment,potentially leading to novel strategies for enhancing functional recovery in SCI patients.
Ying Gao;Ziwen Shi;Suhe Zhang;Zhiqiang Wu;Tao Zhou;Pinghui Zhou;Weiwei Chu;Xuyi Wang
Department of Anesthesiology,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,ChinaDepartment of Orthopaedics,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,ChinaDepartment of Orthopaedics,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,ChinaDepartment of Orthopaedics,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,ChinaAnhui Province Key Laboratory of Tissue Transplantation,Bengbu Medical University,Bengbu 233000,ChinaDepartment of Orthopaedics,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,China Anhui Province Key Laboratory of Tissue Transplantation,Bengbu Medical University,Bengbu 233000,ChinaDepartment of Plastic Surgery,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,ChinaDepartment of Orthopaedics,the First Affiliated Hospital of Bengbu Medical University,Bengbu 233004,China Anhui Province Key Laboratory of Tissue Transplantation,Bengbu Medical University,Bengbu 233000,China
医药卫生
spinal cord injurycerebrospinal fluidexosomemiR-146a-3pUCHL1neural stem cel
《Acta Biochimica et Biophysica Sinica》 2026 (4)
P.895-910,16
supported by the grants from the Natural Science Foundation of Anhui Province(No.2408085MH236)the Natural Science Research Project of Anhui Educational Committee(Nos.2024AH051245,2024AH051284 and 2023AH051935)the Health Research Program of Anhui(Nos.AHWJ2023A30127,AHWJ2023A20228,and AHWJ2021A009)the Natural Science Project of Bengbu Medical University(No.2023byzd054).
评论